Search Results

Orphan designation: proteolytic enzymes enriched in bromelain for the treatment of partial deep dermal and full-thickness burns, 30 Jul 2002, expired (updated) (EU/3/02/107).

• Source: Chemical Business NewsBase (UK), February 15, 2023, 2pp

Record details

MediWound begins Phase II trial of EscharEx to treat chronic wounds.

• Source: Chemical Business NewsBase (UK), May 22, 2014, 1pp

Record details

Opinion/decision on a Paediatric Investigation Plan (PIP): NexoBrid, concentrate of proteolytic enzymes in bromelain. Therapeutic area: Dermatology/other (updated) (EMEA-000142-PIP02-09-M03).

• Source: Chemical Business NewsBase (UK), May 14, 2014, 2pp

Record details

Opinion/decision on a Paediatric investigation plan (PIP): NexoBrid, Concentrate of proteolytic enzymes in bromelain. Therapeutic area: Dermatology/Other (updated) (EMEA-000142-PIP02-09-M05).

• Source: Chemical Business NewsBase (UK), March 20, 2017, 2pp

Record details

Opinion/decision on a Paediatric investigation plan (PIP): NexoBrid, Concentrate of proteolytic enzymes in bromelain. Therapeutic area: Dermatology/Other (updated) (EMEA-000142-PIP02-09-M05).

• Source: Chemical Business NewsBase (UK), March 20, 2017, 2pp

Record details

Going To Extremes

• Authors : By:Photographed by Bruce Weber.

• Source: Vogue, April 1, 2013 Fashion & Features, p. 282 22pp

Record details

Nibbles: Enzyme plays a role in fat control, exercising after a heart attack and fire crews needed to rescue obese

• Authors : By:sarah

• Source: CalorieLab, March 17, 2009 CalorieLab, 9pp

Record details